What are the possible side effects of taking vemurafenib/zobovo?

Vemurafenib/zobovo(Vemurafenib), as an inhibitor targeting BRAF V600E mutation, has played an important role in the treatment of melanoma. However, like other anti-cancer drugs, its use may be accompanied by certain side effects. Understanding these adverse reactions can help patients better cope with them during treatment and work with their doctors to manage them.

One of the most common side effects is skin-related reactions. Vemurafenib may cause rash, photosensitivity reactions, itching, and even squamous cell carcinoma or keratoacanthoma of the skin in some patients. Such adverse reactions often require dermatological follow-up and sometimes surgical excision or use of sun protection to reduce risk.

Secondly, joint pain and muscle discomfort are also common symptoms. Some patients will experience joint stiffness or body aches during medication. Although most of them are controllable, in severe cases, they may affect daily activities and require symptomatic treatment.

Gastrointestinal adverse effects are also common and include nausea, vomiting, diarrhea, and loss of appetite. These symptoms can often be relieved with dietary modifications or symptomatic medications. At the same time, fatigue and weakness often occur, and some patients need to adjust their daily routine to adapt to the treatment.

In terms of laboratory monitoring indicators, vemurafenib may cause increased liver function indicators or electrolyte abnormalities, which need to be monitored through regular blood tests. In addition, the drug may also cause QT interval prolongation, which is a change in the electrical activity of the electrocardiogram, which requires special clinical attention because it may increase the risk of arrhythmia.

Some patients may also experience hair loss, weight loss, or taste changes during long-term treatment. Although these are not life-threatening, they will affect their quality of life. Doctors often adjust the dose or briefly discontinue the medication if necessary, depending on the severity of the side effects.

Reference: https://www.drugs.com/mtm/vemurafenib.html